# Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes

> **NCT01157403** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Lu Debin** · enrollment: 80 (estimated)

## Conditions studied

- Evidence of Liver Transplantation

## Interventions

- **BIOLOGICAL:** Autologous transplantation

## Key facts

- **NCT ID:** NCT01157403
- **Lead sponsor:** Lu Debin
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-07
- **Primary completion:** 2014-07
- **Final completion:** 2014-08
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2013-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01157403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01157403, "Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01157403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*